DW Healthcare Partners announces sale of DermLite to FotoFinder Systems

DW Healthcare Partners (DWHP), a distinguished private equity firm specializing in healthcare, has successfully completed the sale of DermLite Holdco I, Inc. (DermLite) to FotoFinder Systems GmbH, a leading entity in skin cancer detection technology and a portfolio company of EMZ Partners. This acquisition marks a pivotal moment in the dermatological and skin cancer detection industry, promising advancements and expanded capabilities through the synergy of two complementary businesses.

DermLite, a California-based innovator in the field of dermoscopy tools and a portfolio company of DW Healthcare Partners’ Founders Fund, is renowned for its development and manufacturing of dermatoscopes and phone adapters. These critical tools empower dermatologists and healthcare professionals to detect skin cancer and various skin conditions with enhanced precision through advanced magnification lenses and LED lighting.

FotoFinder Systems GmbH, headquartered in Germany, stands at the forefront of early skin cancer detection technology. The company specializes in Automated Total Body Mapping, artificial intelligence, and digital dermoscopy. With subsidiaries in Italy, the UK, and the U.S., and a vast global partner network, FotoFinder serves clients in over 90 countries, affirming its position as a global leader in the dermatology field.

John Bottjer, President of DermLite, expressed enthusiasm about the merger, stating, “DermLite and FotoFinder are two complementary businesses that together create a strong global player in skin imaging and dermoscopy. It is a very exciting time for both companies!”

Thorsten Trotzenberg, Chief Product Officer at DermLite, acknowledged DWHP’s significant role in DermLite’s growth, saying, “We would like to thank the team at DWHP for their support over the last three years. They have been excellent partners and have made significant contributions to the continued growth and success at DermLite.”

Gabe Becher, Managing Director at DWHP, reciprocated the sentiment, highlighting the fruitful collaboration with DermLite and expressing eagerness to see the brand’s continued success under the new ownership of FotoFinder and EMZ.

The acquisition of DermLite by FotoFinder represents a strategic move that not only enhances the capabilities and product offerings of both companies but also signifies a step forward in the global effort to combat skin cancer through innovative technology. The merger is expected to drive advancements in skin imaging and dermoscopy, benefiting healthcare professionals and patients worldwide with cutting-edge tools for early detection and diagnosis of skin cancer and other skin conditions.